Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial ; volume:14 ; number:1 ; day:8 ; month:3 ; year:2016 ; pages:1-11 ; date:12.2016
BMC medicine ; 14, Heft 1 (8.3.2016), 1-11, 12.2016
- Urheber
-
Gonçalves, Bronner P.
- Beteiligte Personen und Organisationen
-
Tiono, Alfred B.
Ouédraogo, Alphonse
Guelbéogo, Wamdaogo M.
Bradley, John
Nébié, Issa
Siaka, Débé
Lanke, Kjerstin
Eziefula, Alice C.
Diarra, Amidou
Pett, Helmi
Bougouma, Edith C.
Sirima, Sodiomon B.
Drakeley, Chris
Bousema, Teun
SpringerLink (Online service)
- DOI
-
10.1186/s12916-016-0581-y
- URN
-
urn:nbn:de:1111-2016031027876
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gonçalves, Bronner P.
- Tiono, Alfred B.
- Ouédraogo, Alphonse
- Guelbéogo, Wamdaogo M.
- Bradley, John
- Nébié, Issa
- Siaka, Débé
- Lanke, Kjerstin
- Eziefula, Alice C.
- Diarra, Amidou
- Pett, Helmi
- Bougouma, Edith C.
- Sirima, Sodiomon B.
- Drakeley, Chris
- Bousema, Teun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
Rationale for short course primaquine in Africa to interrupt malaria transmission
Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
Rationale for short course primaquine in Africa to interrupt malaria transmission
Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
Rationale for short course primaquine in Africa to interrupt malaria transmission
Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)